Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Design and Synthesis of Tumor Targeted Agents from Biologically Active Natural Products (Neocarzinostatin, Xanthine).

Design and Synthesis of Tumor Targeted Agents from Biologically Active Natural Products (Neocarzinostatin, Xanthine).

Ma, Dong

Paperback

Chemistry

Currently unavailable to order

ISBN10: 1243518391
ISBN13: 9781243518392
Publisher: Proquest Umi Dissertation Pub
Pages: 272
Weight: 1.20
Height: 0.71 Width: 7.99 Depth: 10.00
Language: English
Recently, the subject of tumor targeted therapy has drawn more and more attention as a result of increasing knowledge of biology and physiology. A tumor specific agent with high therapeutic index, good bioavailability and easy preparation is highly preferred. To achieve this goal, rational design and development of synthetic lead compounds based on active natural products remain as the most successful strategy in cancer chemotherapy. It serves as both the objective and the philosophy of this thesis and is demonstrated in the following two areas of research. Bulges are unpaired nucleotides on one strand of the DNA double helix. They have been linked to many biomolecular processes including cancer. Agents with high specificity to bulges would be of considerable utility to the biological research community for the discovery of active anti-tumor entities. NCSi-gb is a natural metabolite of neocarzinostatin chromophore (NCS chrom), an anti-tumor antibiotic. It was found to bind specifically to bulged DNA at nanomolar concentration due to its unique wedge-shaped spirocyclic structure. Modeled on the molecule, mimics of NCSi-gb were rationally designed and a synthetic route was devised and executed to prepare them. These analogues showed nanomolar binding affinity and two-base bulge specificity. In a second area of my research, tumor targeting is investigated using in a prodrug approach based on the A2A receptor mediated tumor escape mechanism in T-cells. A prodrug of KW6002, an 8-substituted xanthine, was designed and synthesized. The proof-of-principle study validated the design for enzyme activated drug release. A major obstacle to accessibility of this class of compounds is the tedious two-step cyclization for the formation of xanthine's five-membered rings. Therefore, a novel one-pot methodology for the preparation of 8-substituted xanthines was developed. Using this methodology, the key intermediate for the preparation of the tumor targeting prodrug was more efficiently synthesized, along with a number of analogues.

Also in

Chemistry

View All